hormone glp-1 drugs protect brain health by improving neurovascular function and reducing inflammation GLP-1's: What They Are and

Variants in the GLP1R and other peptide-pathway genes may influence how your body responds to GLP-1 medications during both steady-state and acute illness

Ethics statement The studies involving humans were approved by Ethical Committees of the Instituto de Biologa y Medicina Experimental, Buenos Aires (Ref: CE 001/April 2019)

GLP-1RAs are currently available as twice-daily (exenatide), once-daily (liraglutide and lixisenatide), or once-weekly subcutaneous injections (semaglutide, dulaglutide, and exenatide extended-release) and as a once-daily tablet for oral administration (oral semaglutide) (Table 1) [37]

PMID: 16763547 USP General Chapter 797: Pharmaceutical Compounding Sterile Preparations